Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.verified

ICPT

Price:

$19

Market Cap:

$794.69M

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United State...[Read more]

Industry

Biotechnology

IPO Date

2012-10-11

Stock Exchange

NASDAQ

Ticker

ICPT

The Current Ratio as of June 2024 (TTM) for Intercept Pharmaceuticals, Inc. (ICPT) is 4.22

According to Intercept Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.22. This represents a change of 47.41% compared to the average of 2.86 of the last 4 quarters.

Intercept Pharmaceuticals, Inc. (ICPT) Historical Current Ratio (quarterly & annually)

How has ICPT Current Ratio performed in the past?

The mean historical Current Ratio of Intercept Pharmaceuticals, Inc. over the last ten years is 7.63. The current 4.22 Current Ratio has changed 5.43% with respect to the historical average. Over the past ten years (40 quarters), ICPT's Current Ratio was at its highest in in the June 2015 quarter at 31.15. The Current Ratio was at its lowest in in the March 2014 quarter at 0.48.

Quarterly (TTM)
Annual

Average

7.63

Median

4.38

Minimum

2.35

Maximum

16.61

Intercept Pharmaceuticals, Inc. (ICPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Intercept Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.70%

Maximum Annual Current Ratio = 16.61

Minimum Annual Increase = -52.20%

Minimum Annual Current Ratio = 2.35

Quarterly (TTM)
Annual
YearCurrent RatioChange
20222.35-22.03%
20213.0113.00%
20202.66-40.15%
20194.455.40%
20184.22-1.97%
20174.31-52.20%
20169.02-33.44%
201513.55-16.02%
201416.13-2.92%
201316.6192.70%

Intercept Pharmaceuticals, Inc. (ICPT) Average Current Ratio

How has ICPT Current Ratio performed in the past?

The current Current Ratio of Intercept Pharmaceuticals, Inc. (ICPT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

2.67

5-year avg

3.34

10-year avg

7.63

Intercept Pharmaceuticals, Inc. (ICPT) Current Ratio vs. Peers

How is ICPT’s Current Ratio compared to its peers?

Intercept Pharmaceuticals, Inc.’s Current Ratio is less than Viking Therapeutics, Inc. (29.48), less than Terns Pharmaceuticals, Inc. (27.85), less than Akero Therapeutics, Inc. (30.12), greater than Reata Pharmaceuticals, Inc. (3.21), less than Madrigal Pharmaceuticals, Inc. (9.39), greater than TG Therapeutics, Inc. (3.62), less than Hepion Pharmaceuticals, Inc. (5.99), greater than PTC Therapeutics, Inc. (2.03), less than Krystal Biotech, Inc. (12.66), less than AVROBIO, Inc. (26.17), greater than CohBar, Inc. (4.16), greater than Ocean Biomedical, Inc. (0.03), greater than Enveric Biosciences, Inc. (3.48), less than Elevation Oncology, Inc. (46.22), greater than Sarepta Therapeutics, Inc. (4.05), less than Mirati Therapeutics, Inc. (7.54),

Build a custom stock screener for Intercept Pharmaceuticals, Inc. (ICPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intercept Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intercept Pharmaceuticals, Inc. (ICPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intercept Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Intercept Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Intercept Pharmaceuticals, Inc. (ICPT)?

What is the highest Current Ratio for Intercept Pharmaceuticals, Inc. (ICPT)?

What is the 3-year average Current Ratio for Intercept Pharmaceuticals, Inc. (ICPT)?

What is the 5-year average Current Ratio for Intercept Pharmaceuticals, Inc. (ICPT)?

How does the current Current Ratio for Intercept Pharmaceuticals, Inc. (ICPT) compare to its historical average?